Boc-leu-lys-arg-amc hydrochloride salt
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-leu-lys-arg-amc hydrochloride salt

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Boc-LKR-AMC is a good substrate for the Kex2 endoprotease.

Category
Others
Catalog number
BAT-015875
CAS number
109358-47-6
Molecular Formula
C33H52N8O7
Molecular Weight
672.82
Boc-leu-lys-arg-amc hydrochloride salt
IUPAC Name
tert-butyl N-[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-(diaminomethylideneamino)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate
Synonyms
4-Methyl-7-(Boc-L-Leu-L-Lys-L-Arg-amino)-2H-1-benzopyran-2-one; Boc-LKR-AMC
Purity
95%
Sequence
Boc-Leu-Lys-Arg-AMC
Storage
Store at -20°C
InChI
InChI=1S/C33H52N8O7/c1-19(2)16-25(41-32(46)48-33(4,5)6)30(45)40-23(10-7-8-14-34)29(44)39-24(11-9-15-37-31(35)36)28(43)38-21-12-13-22-20(3)17-27(42)47-26(22)18-21/h12-13,17-19,23-25H,7-11,14-16,34H2,1-6H3,(H,38,43)(H,39,44)(H,40,45)(H,41,46)(H4,35,36,37)/t23-,24-,25-/m0/s1
InChI Key
RRHPIUJOSIJECH-SDHOMARFSA-N
Canonical SMILES
CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C
1.Application of Design of Experiments for Formulation Development and Mechanistic Evaluation of Iontophoretic Tacrine Hydrochloride Delivery.
Patel N1, Jain S1, Madan P1, Lin S1. Drug Dev Ind Pharm. 2016 Apr 21:1-32. [Epub ahead of print]
OBJECTIVE: The objective of this investigation is to develop mathematical equation to understand the impact of variables and establish statistical control over transdermal iontophoretic delivery of tacrine hydrochloride. In addition, possibility of using conductivity measurements as a tool of predicting ionic mobility of the participating ions for the application of iontophoretic delivery was explored.
2.Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt.
Manniello MD1, Gaudio PD1, Porta A1, Aquino RP1, Russo P2. Eur J Pharm Biopharm. 2016 Apr 19. pii: S0939-6411(16)30133-3. doi: 10.1016/j.ejpb.2016.04.009. [Epub ahead of print]
Antibiotic therapy for a direct administration to the lung in cystic fibrosis patients has to provide suitable availability, possibly in the lower respiratory tract, characterized by the presence of thick secretions. One of the crucial step in the therapeutic management of the respiratory disease could be the drug solubilization directly in this site of action. The aim of the study was to prepare respirable powders of clarithromycin, while improving drug aqueous solubility. With this aim, several batches of micronized particles were prepared by spray drying different feed solutions, varying the solvent composition (water/isopropyl alcohol ratio), the drug concentration and pH of the liquid feeds. Particle size distribution of raw materials and engineered particles was determined using a light-scattering laser granulometer while particle morphology was assessed by scanning electron microscopy. The in vitro deposition of the micronized clarithromycin powders was evaluate by means of a Single-Stage Glass Impinger using the RS01 model7 by Plastiape® as device for the aersolization.
3.Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids.
Czarniak P1, Boddy M1, Sunderland B1, Hughes JD1. Drug Des Devel Ther. 2016 Mar 7;10:1029-34. doi: 10.2147/DDDT.S94710. eCollection 2016.
PURPOSE: The purpose of this study was to evaluate the chemical stability of Lincocin(®) (lincomycin hydrochloride) in commonly used intravenous fluids at room temperature (25°C), at accelerated-degradation temperatures and in selected buffer solutions.
Online Inquiry
Verification code
Inquiry Basket